ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Scientist at Kernal Biologics, Inc. - ApplyBlast

Senior Scientist

Kernal Biologics, Inc.

13 days ago

Boston, Massachusetts, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Kernal Bio is seeking a Senior Scientist to develop and characterize its targeting lipid nanoparticle platform, supporting the manufacturing process and tech transfer. The role involves designing and executing experiments, analyzing results, and contributing to the optimization of LNP/mRNA manufacturing processes. The successful candidate will collaborate with internal teams and external partners in a fast-paced biotech environment.

Responsibilities

Develop and characterize novel LNP formulations and manufacturing processes
Execute in vivo experiments and screen formulation buffers for stability
Support technology transfer activities and analyze experimental results

Skills

Qualifications

PhD in Chemical EngineeringPhD in Biomedical EngineeringPhD in BioengineeringPhD in PharmaceuticsPhD in Chemistry

About Kernal Biologics, Inc.

kernalbio.com

Headquarters

Cambridge, Massachusetts, United States

Company Size

11-50 employees

Founded

2016

View Profile

Kernal Biologics is an onco-selective mRNA therapeutics company based in Cambridge, MA that develops in vivo cell therapies by programming cells directly inside the body through targeted delivery and selective translation. Their platform uses state-of-the-art AI models to ensure selective mRNA translation in target cells, enabling scalable in vivo CAR-T therapies for patients with cancer and auto-immune diseases. Kernal overcomes the manufacturing, cost, and accessibility limitations of current ex vivo cell therapies and has received up to $48 million in funding from ARPA-H to advance its pipeline.